{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-7A",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-7A.json",
  "legislation": "uksi/2013/2033",
  "legislation_title": "The Veterinary Medicines Regulations 2013",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013",
  "path": "schedule/7/paragraph/7A",
  "kind": "paragraph",
  "number": "7A",
  "heading": "Application for a marketing authorisation for specific applications",
  "text": "The fee for an application for a marketing authorisation which involves one or more of the following is £45,000—\n(a) any biotechnical process involving recombinant DNA or the controlled expression of genes;\n(b) a veterinary medicinal product containing a new active substance;\n(c) a biopharmaceutical product.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. 7 para. 7A inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 165"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/2033/schedule/7/paragraph/7A",
    "retrieved_at": "2026-10-29T00:44:44.019972+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}